A Brian Davis - Net Worth and Insider Trading
A Brian Davis Net Worth
The estimated net worth of A Brian Davis is at least $16,061 dollars as of 2024-11-29. A Brian Davis is the CFO of Verrica Pharmaceuticals Inc and owns about 12,900 shares of Verrica Pharmaceuticals Inc (VRCA) stock worth over $16,061. Details can be seen in A Brian Davis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that A Brian Davis has not made any transactions after 2021-06-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of A Brian Davis
A Brian Davis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, A Brian Davis owns 4 companies in total, including Verrica Pharmaceuticals Inc (VRCA) , Strongbridge Biopharma PLC (SBBP) , and Tengion Inc (TNGNQ) among others .
Click here to see the complete history of A Brian Davis’s form 4 insider trades.
Insider Ownership Summary of A Brian Davis
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
VRCA | Verrica Pharmaceuticals Inc | 2021-06-04 | Chief Financial Officer |
SBBP | Strongbridge Biopharma PLC | 2019-02-20 | Chief Financial Officer |
TNGNQ | Tengion Inc | 2013-03-04 | Chf. Fin. Offr & VP Fin. |
2023-10-10 | director |
A Brian Davis Latest Holdings Summary
A Brian Davis currently owns a total of 1 stock. A Brian Davis owns 12,900 shares of Verrica Pharmaceuticals Inc (VRCA) as of June 4, 2021, with a value of $16,061.
Latest Holdings of A Brian Davis
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
VRCA | Verrica Pharmaceuticals Inc | 2021-06-04 | 12,900 | 1.25 | 16,061 |
Holding Weightings of A Brian Davis
A Brian Davis Form 4 Trading Tracker
According to the SEC Form 4 filings, A Brian Davis has made a total of 2 transactions in Verrica Pharmaceuticals Inc (VRCA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Verrica Pharmaceuticals Inc is the acquisition of 5,000 shares on June 4, 2021, which cost A Brian Davis around $49,450.
Insider Trading History of A Brian Davis
- 1
A Brian Davis Trading Performance
GuruFocus tracks the stock performance after each of A Brian Davis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by A Brian Davis is 40.35%. GuruFocus also compares A Brian Davis's trading performance to market benchmark return within the same time period. The performance of stocks bought by A Brian Davis within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how A Brian Davis's insider trading performs compared to the benchmark.
Performance of A Brian Davis
A Brian Davis Ownership Network
A Brian Davis Owned Company Details
What does Verrica Pharmaceuticals Inc do?
Who are the key executives at Verrica Pharmaceuticals Inc?
A Brian Davis is the Chief Financial Officer of Verrica Pharmaceuticals Inc. Other key executives at Verrica Pharmaceuticals Inc include director & President and CEO Ted White , Chief Commercial Officer Joe Bonaccorso , and General Counsel Christopher G. Hayes .
Verrica Pharmaceuticals Inc (VRCA) Insider Trades Summary
Over the past 18 months, A Brian Davis made no insider transaction in Verrica Pharmaceuticals Inc (VRCA). Other recent insider transactions involving Verrica Pharmaceuticals Inc (VRCA) include a net sale of 150,999 shares made by Ted White , a net sale of 130,386 shares made by Joe Bonaccorso , and a net sale of 124,941 shares made by Christopher G. Hayes .
In summary, during the past 3 months, insiders sold 0 shares of Verrica Pharmaceuticals Inc (VRCA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 533,677 shares of Verrica Pharmaceuticals Inc (VRCA) were sold and 2,260,199 shares were bought by its insiders, resulting in a net purchase of 1,726,522 shares.
Verrica Pharmaceuticals Inc (VRCA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verrica Pharmaceuticals Inc Insider Transactions
A Brian Davis Mailing Address
Above is the net worth, insider trading, and ownership report for A Brian Davis. You might contact A Brian Davis via mailing address: C/o Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester Pa 19380.